Details for New Drug Application (NDA): 050566
✉ Email this page to a colleague
NDA 050566 describes ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in one NDA. Additional details are available on the ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER profile page.
The generic ingredient in ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
The generic ingredient in ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
Summary for 050566
| Tradename: | ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER |
| Applicant: | Baxter Hlthcare |
| Ingredient: | cefazolin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050566
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG BASE/ML | ||||
| Approval Date: | Jun 8, 1983 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 20MG BASE/ML | ||||
| Approval Date: | Jun 8, 1983 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG BASE/ML | ||||
| Approval Date: | Jun 8, 1983 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
